Global Mechanical Ventilator Market to 2027 - Size, Share & Industry Trends Analysis Report'

(MENAFN- PR Newswire)

DUBLIN, April 14, 2022 /PRNewswire/ -- The 'Global Mechanical Ventilator market Size, Share & industry Trends Analysis Report By Product Type, By Age Group, By Component (Devices and Services), By Mode, By End User, By Regional Outlook and Forecast, 2021-2027' report has been added to ResearchAndMarkets.com's offering.

The Global Mechanical Ventilator Market size is expected to reach $11.7 billion by 2027, rising at a market growth of 12.7% CAGR during the forecast period.

Mechanical ventilator is the device used to support breathing of patients who is critically ill and unable to breathe by self. A hollow tube, which acts as artificial airway, is inserted into the patient's mouth and down into their trachea to connect patient to the ventilator. In addition, mechanical ventilators are used to assess static compliance of airway resistance and respiratory system abnormalities as a diagnostic tool. The mechanical ventilators market is a life-saving device in medical emergency and surgeries. These devices are majorly used for patients with spinal cord injury, stroke, respiratory disorders, or other disorders.The growth of the global mechanical ventilator market is majorly driven by increase in prevalence of chronic respiratory diseases such as lung cancer, chronic obstructive pulmonary disease (COPD), asthma, bronchitis, and other lung disorders as well as rise in number of hospitals & diagnostic centers. As per the Globocan 2020, lung cancer is a second ranked cancer in terms of patient count in Europe with estimated 477,534 newly diagnosed patients.In addition, increase in aged individuals who are susceptible to respiratory disorders is one of the key drivers of the market. For instance, according to the American Cancer Society's 2021 Statistics, most of the people over the age of 65 are prone to lung cancer.Moreover, advancements in mechanical ventilator Market anticipated to contribute toward the growth of the market. For instance, Philips, a global leader in health technology, offers Respironics V680, a critical care ventilator which uses their proprietary auto-trak technology to automatically adapt to your patient's breathing pattern and deliver a high level of synchrony during noninvasive therapy. COVID-19 Impact Analysis

Furthermore, COVID-19 pandemic has boosted the growth of market. The COVID-19 infection is associated with respiratory failure, and requires critical care with ventilator support. Mechanical ventilation has regularly been employed to oxygenate seriously ill COVID-19 patients. In addition, new delta and omicron variants of COVID-19 with high spreading rate found in mid-November 2021 have increased the risk of third wave across the world. Moreover, key manufacturing companies in mechanical ventilators market and government have taken initiatives to boost the production of market to fulfil the high requirement of ventilators during the pandemic.Thus, presence of various manufacturers and initiatives taken by government to increase the production of market propelled the growth of the market. However, high cost associated with mechanical ventilators and risk of ventilator associated diseases such as nosocomial pneumonias restrict the market growth during the forecast period. Market Growth Factors:

Increasing number of ICU Admissions is augmenting he demand for critical care

The burden of respiratory diseases is rising globally, owing to numerous factors such as smoking, obesity, and lifestyle changes. According to the Regents of the University of California, in the United States, approximately 4 million ICU admissions are registered each year. In Germany, around 2.1 million patients are admitted in ICU each year, out of which an estimated 42.0% patients require mechanical ventilation. The increasing demand for critical care equipment, due to increasing number of ICU admissions in emerging and developed countries are some of the major factors anticipated to drive the growth of the market. Additionally, the impact of COVID-19, the number of ICU admissions had an additional impact and the need of critical care equipment. Soaring Innovations In Intensive Care Unit (ICU) Ventilation

Potential optimization of ventilation bundles begins by re-investigating the critical constituents of respiratory mechanics. Automation of ventilation settings could result in a solution. Closed-loop systems have been categorized into clear, physiological signal-based, and explicit computerized protocols or ECP. ECP systems utilize numerous inputs to curb one or numerous ventilator outputs.Certain examples of automation of mechanical ventilation include Adaptive Support Ventilation (ASV; which titrates ventilator output on a breath-to-breath basis offering a preset level of minute ventilation while reducing work of breathing), Intelligent ASV (an expansion of ASV, inclusive of an automatized choice of FiO2 and PEEP), and SmartCarePS (regulation of pressure support level based on the patient's respiratory features). Additional examples accessible on the market (although not completely automatized) are proportional assisted ventilation plus (PAV+) and NAVA. The modes of ventilation include non-invasive ventilation and invasive ventilation. Marketing Restraining Factor:

High Capital Requirement

Purchasing a fleet of ventilators for hospital is a major decision. The cost of acquiring new equipment is part of that decision-making process. There are many ventilator options available to care for a variety of patient needs. Examples include: Home care ventilators, Transport ventilators, Low, medium, and high-acuity ventilators, High-frequency ventilators, Noninvasive positive pressure ventilation/continuous positive airway pressure (NPPV/CPAP), bi-level positive airway pressure (BIPAP) systems.

Different ventilators also have different gas delivery designs, including turbine-based air supply and proportional solenoid (PSOL) valve control, or a combination of the two systems. Costs for these ventilators can range from $5,000 to $50,000. Premium or high-acuity ventilators - most commonly found in hospital ICUs - typically have a PSOL gas delivery design and can currently cost between $25,000 and $50,000.

Key Topics Covered: Chapter 1. Market Scope & Methodology Chapter 2. Market Overview 2.1 Introduction2.1.1 Overview2.1.1.1 Market Composition and Scenario2.2 Key Factors Impacting the Market2.2.1 Market Drivers2.2.2 Market Restraints Chapter 3. Competition Analysis - Global 3.1 KBV Cardinal Matrix3.2 Recent Industry Wide Strategic Developments3.2.1 Partnerships, Collaborations and Agreements3.2.2 Product Launches and Product Expansions3.2.3 Acquisition and Mergers3.2.4 Geographical Expansions3.2.5 Approvals and Trials3.3 Top Winning Strategies3.3.1 Key Leading Strategies: Percentage Distribution (2017-2021)3.3.2 Key Strategic Move: (Partnerships, Collaborations and Agreements: 2020, Mar - 2021, Jan) Leading Players Chapter 4. Global Mechanical Ventilator Market by Product Type 4.1 Global Intensive Care Unit/Critical Care Market by Region4.2 Global Transport/Portable/Ambulatory Market by Region4.3 Global Neonatal Care Market by Region Chapter 5. Global Mechanical Ventilator Market by Age Group 5.1 Global Adult Market by Region5.2 Global Geriatric Market by Region5.3 Global Pediatric & Neonatal Market by Region Chapter 6. Global Mechanical Ventilator Market by Component 6.1 Global Devices Market by Region6.2 Global Services Market by Region Chapter 7. Global Mechanical Ventilator Market by Mode 7.1 Global Invasive Ventilation Market by Region7.2 Global Non-Invasive Ventilation Market by Region Chapter 8. Global Mechanical Ventilator Market by End User 8.1 Global Hospital & Clinic Market by Region8.2 Global Ambulatory Surgical Center Market by Region8.3 Global Home Care Market by Region8.4 Global Others Market by Region Chapter 9. Global Mechanical Ventilator Market by Region Chapter 10. Company Profiles 10.1 General Electric (GE) Co. (GE Healthcare)10.1.1 Company Overview10.1.2 Financial Analysis10.1.3 Segmental and Regional Analysis10.1.4 Research & Development Expense10.1.6 SWOT Analysis10.2 Koninklijke Philips N.V.10.2.1 Company Overview10.2.2 Financial Analysis10.2.3 Segmental and Regional Analysis10.2.4 Research & Development Expense10.3 Medtronic PLC10.3.1 Company overview10.3.2 Financial Analysis10.3.3 Segmental and Regional Analysis10.3.4 Research & Development Expenses10.4 Dragerwerk AG & Co. KGaA10.4.1 Company Overview10.4.2 Financial Analysis10.4.3 Segmental and Regional Analysis10.4.4 Research & Development Expense10.5 Getinge AB10.5.1 Company Overview10.5.2 Financial Analysis10.5.3 Segmental and Regional Analysis10.5.4 Research & Development Expense10.6 Asahi Kasei Corporation (Zoll Medical Corporation)10.6.1 Company Overview10.6.2 Financial Analysis10.6.3 Segmental and Regional Analysis10.6.4 Research & Development Expense10.7 Hamilton Medical AG (Hamilton Bonaduz AG)10.7.1 Company Overview10.8 Carl Reiner GmbH10.8.1 Company Overview10.9 Mindray Medical International Limited10.9.1 Company Overview10.10. Vyaire Medical, Inc.10.10.1 Company Overview

For more information about this report visit

Media Contact:

Research and MarketsLaura Wood, Senior Manager[email protected]

For E.S.T Office Hours Call +1-917-300-0470 For U.S./CAN Toll Free Call +1-800-526-8630For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1904Fax (outside U.S.): +353-1-481-1716

SOURCE Research and Markets

MENAFN14042022003732001241ID1104028379